European Journal of Pain · 2015 · 67 citations · 32 references
MedicineNeurologyNeural EngineeringPain ManagementPain MedicineHeadache AssessmentHeadache DisordersHeadache ManagementNeurostimulationSpinal Cord StimulationChronic HeadacheHeadache DiaryHeadache Frequency AssessmentHigh-frequency Spinal Cord StimulationMigraine ChronicityOnabotulinumtoxina TherapyRefractory HeadacheRefractory Migraine Management
BACKGROUND: A significant minority of chronic migraine (CM) subjects fail conventional medical treatment (rCM), becoming highly disabled. Implantation of an occipital nerve stimulator is a therapeutic option for these subjects. Paresthesia-free cervical 10 kHz spinal cord stimulation (HF10 SCS) may provide an alternative. We report the results of a prospective, open-label, exploratory study assessing the long-term safety, tolerability and efficacy of cervical HF10 SCS in cohort of rCM subjects. METHODS: Included subjects were diagnosed with CM by an experienced headache specialist with the aid of an hourly headache diary. They were refractory to conventional medical treatments including onabotulinumtoxin-A injections. Medication overuse headache was not an exclusion criteria. Enrolled subjects underwent a 2- to 4-week tunnelled cervical HF10 SCS trial followed by a permanent system implant if a significant, subjective reduction in headache intensity/episodes was reported during the trial. Subjects were evaluated at baseline and 6 months after implantation with the aid of monthly diaries and headache-specific questionnaires. RESULTS: Seventeen subjects underwent a trial of cervical HF10 SCS; 14 were still implanted at 6 months (one trial failure, one trial infection, one implant site infection). Seven of the 14 subjects had >30% reduction in headache days. The average reduction in headache days was 6.9 for the overall population and 12.9 among the responders. Three subjects reported tenderness over the IPG/connection site, and one had a lead migration that required surgical revision. CONCLUSION: Paresthesia-free cervical HF10 SCS may be a safe and effective therapeutic option for chronic migraineurs refractory to conventional treatments.
32
A 12-Item Short-Form Health Survey
John E. Ware, Mark Kosinski, Susan Keller · Medical Care · 1996 · 17.1K citations
Theo Vos, Abraham D Flaxman, Mohsen Naghavi et al. · The Lancet · 2012 · 8.4K citations · Full text
The International Classification of Headache Disorders: 2nd edition
Jes Olesen, Peter J. Goadsby, Tim Steiner · The Lancet Neurology · 2003 · 5.1K citations
Medicine, Neurology, Psychiatry +13
Patient non-compliance with paper diaries
Arthur A. Stone · BMJ · 2002 · 822 citations · Full text